These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35870026)

  • 41. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Case of COVID-19 Vaccine Causing a Myasthenia Gravis Crisis.
    Tagliaferri AR; Narvaneni S; Azzam MH; Grist W
    Cureus; 2021 Jun; 13(6):e15581. PubMed ID: 34277203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AChR-specific immunosuppressive therapy of myasthenia gravis.
    Luo J; Lindstrom J
    Biochem Pharmacol; 2015 Oct; 97(4):609-619. PubMed ID: 26215875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases.
    Karimi N; Okhovat AA; Ziaadini B; Haghi Ashtiani B; Nafissi S; Fatehi F
    Clin Neurol Neurosurg; 2021 Sep; 208():106834. PubMed ID: 34329810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
    Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
    Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2.
    Shah SMI; Yasmin F; Memon RS; Jatoi NN; Savul IS; Kazmi S; Monawwer SA; Zafar MDB; Asghar MS; Tahir MJ; Lee KY
    Brain Behav; 2022 Dec; 12(12):e2789. PubMed ID: 36306401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report.
    Yanagihashi M; Okamoto R; Morioka H; Sawada M; Matsumoto S; Ikeda T; Kano O
    BMC Neurol; 2020 Aug; 20(1):319. PubMed ID: 32859168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis.
    Wang HY; Qiu L; Ou CY; Lin ZQ; Huang ZD; Chen P; Ma Q; Lu YR; Ran H; Liu WB
    Neurol Sci; 2023 Jul; 44(7):2239-2245. PubMed ID: 37160544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flare of myasthenia gravis induced by COVID-19 vaccines.
    Ishizuchi K; Takizawa T; Sekiguchi K; Motegi H; Oyama M; Nakahara J; Suzuki S
    J Neurol Sci; 2022 May; 436():120225. PubMed ID: 35290838
    [No Abstract]   [Full Text] [Related]  

  • 53. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine.
    Abicic A; Sitas B; Adamec I; Bilic E; Habek M
    Cureus; 2022 Jul; 14(7):e27213. PubMed ID: 36035038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.
    Giugliano F; Zucali PA; Galli G; Ballatore Z; Corti C; Aliaga PT; Uliano J; Vivanet G; Curigliano G; Conforti F; Queirolo P; Berardi R; Manglaviti S; Apollonio G; Perrino M; Borea F; D'Antonio F; Garassino MC; De Pas T
    Eur J Cancer; 2022 May; 166():202-207. PubMed ID: 35306318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
    Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
    JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between COVID-19 vaccination and myasthenia gravis: A population-based, nested case-control study.
    Arbel A; Bishara H; Barnett-Griness O; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
    Eur J Neurol; 2023 Dec; 30(12):3868-3876. PubMed ID: 37552795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review.
    Rodrigues CL; de Freitas HC; Lima PRO; de Oliveira Junior PH; Fernandes JMA; D'Almeida JAC; Nóbrega PR
    Neurol Sci; 2022 Apr; 43(4):2271-2276. PubMed ID: 35039987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoimmune myasthenia gravis after COVID-19 in a triple vaccinated patient.
    Croitoru CG; Cuciureanu DI; Prutianu I; Cianga P
    Arch Clin Cases; 2022; 9(3):104-107. PubMed ID: 36176496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myasthenia Gravis Exacerbation Following Immunization With the BNT162b2 mRNA COVID-19 Vaccine: Report of a Case and Review of the Literature.
    Papadopoulou M; Stefanou MI; Palaiodimou L; Tsivgoulis G
    Neurohospitalist; 2023 Jul; 13(3):303-307. PubMed ID: 37435091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.